Bo Kong

3.9k total citations · 1 hit paper
64 papers, 2.0k citations indexed

About

Bo Kong is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Bo Kong has authored 64 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Oncology, 27 papers in Molecular Biology and 23 papers in Cancer Research. Recurrent topics in Bo Kong's work include Pancreatic and Hepatic Oncology Research (32 papers), Cancer, Hypoxia, and Metabolism (12 papers) and Epigenetics and DNA Methylation (9 papers). Bo Kong is often cited by papers focused on Pancreatic and Hepatic Oncology Research (32 papers), Cancer, Hypoxia, and Metabolism (12 papers) and Epigenetics and DNA Methylation (9 papers). Bo Kong collaborates with scholars based in Germany, China and United States. Bo Kong's co-authors include Christoph Michalski, Jörg Kleeff, Mert Erkan, Helmut Frieß, Iréne Esposito, Helmut Friess, Susanne Raulefs, Ivonne Regel, Ivane Abiatari and Anna Melissa Schlitter and has published in prestigious journals such as PLoS ONE, Oncogene and Scientific Reports.

In The Last Decade

Bo Kong

63 papers receiving 1.9k citations

Hit Papers

The molecular biology of pancreatic adenocarcinoma: trans... 2021 2026 2022 2024 2021 50 100 150 200

Peers

Bo Kong
Xiangsheng Zuo United States
Yuelin J. Zhu United States
Bo Kong
Citations per year, relative to Bo Kong Bo Kong (= 1×) peers Masanobu Tsubaki

Countries citing papers authored by Bo Kong

Since Specialization
Citations

This map shows the geographic impact of Bo Kong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Kong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Kong more than expected).

Fields of papers citing papers by Bo Kong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bo Kong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Kong. The network helps show where Bo Kong may publish in the future.

Co-authorship network of co-authors of Bo Kong

This figure shows the co-authorship network connecting the top 25 collaborators of Bo Kong. A scholar is included among the top collaborators of Bo Kong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bo Kong. Bo Kong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Luo, Siyuan, Junnan Li, Yuqing Zhou, et al.. (2024). Diisooctyl phthalate (DIOP) exposure leads to cell apoptosis to HUVEC cells and toxicity to Caenorhabditis elegans through increasing the oxidative stress. Ecotoxicology and Environmental Safety. 290. 117594–117594. 2 indexed citations
2.
Sun, Yifeng, Yina Qiao, Yanan Niu, et al.. (2024). ARP2/3 complex affects myofibroblast differentiation and migration in pancreatic ductal adenocarcinoma. International Journal of Cancer. 156(6). 1272–1281. 1 indexed citations
3.
Kong, Bo, Susanne Raulefs, Susanne Roth, et al.. (2022). Sca-1 is a marker for cell plasticity in murine pancreatic epithelial cells and induced by IFN-β in vitro. Pancreatology. 22(2). 294–303. 3 indexed citations
4.
Li, Xiaoxue, Mingyue Hu, Yu Ma, et al.. (2020). CircRHOT1 mediated cell proliferation, apoptosis and invasion of pancreatic cancer cells by sponging miR‐125a‐3p. Journal of Cellular and Molecular Medicine. 24(17). 9881–9889. 19 indexed citations
5.
Ding, Xiwei, Chunyan Peng, Keun Soo Ahn, et al.. (2020). Therapeutic Rationale to Target Highly Expressed Aurora kinase A Conferring Poor Prognosis in Cholangiocarcinoma. Journal of Cancer. 11(8). 2241–2251. 2 indexed citations
6.
Ma, Yu, Yuan Li, Xiaoxue Li, et al.. (2020). Loss of heterozygosity for KrasG12D promotes REDD1-dependent, non-canonical glutamine metabolism in pancreatic ductal adenocarcinoma. Biochemical and Biophysical Research Communications. 526(4). 880–888. 7 indexed citations
7.
Li, Hongzhen, Chunyan Peng, Xiwei Ding, et al.. (2020). ALDH1A3 Accelerates Pancreatic Cancer Metastasis by Promoting Glucose Metabolism. Frontiers in Oncology. 10. 915–915. 39 indexed citations
8.
Yang, Li, Mingming Zhang, Robert Dorfman, et al.. (2018). SIRT2 Promotes the Migration and Invasion of Gastric Cancer through RAS/ERK/JNK/MMP-9 Pathway by Increasing PEPCK1-Related Metabolism. Neoplasia. 20(7). 745–756. 79 indexed citations
9.
Cheng, Tao, Susanne Raulefs, Ivonne Regel, et al.. (2016). In vivo functional dissection of a context-dependent role for Hif1α in pancreatic tumorigenesis. Oncogenesis. 5(12). e278–e278. 4 indexed citations
10.
Kong, Bo, et al.. (2016). Distributed Storage Strategy Based on LT Codes in Space Information Network. 38(4). 787–794. 1 indexed citations
11.
Späth, Christoph, Ulrich Nitsche, Thomas Müller, et al.. (2015). Strategies to improve the outcome in locally advanced pancreatic cancer.. mediaTUM (Technical University of Munich). 70(2). 97–106. 7 indexed citations
12.
Kong, Bo, Philipp Bruns, Susanne Raulefs, et al.. (2015). Metabolism gene signatures and surgical site infections in abdominal surgery. International Journal of Surgery. 14. 67–74. 3 indexed citations
13.
Kong, Bo, Tao Cheng, Weiwei Wu, et al.. (2015). Pancreas-specific activation of mTOR and loss of p53 induce tumors reminiscent of acinar cell carcinoma. Molecular Cancer. 14(1). 212–212. 8 indexed citations
14.
Michalski, Christoph, Bo Kong, Carsten Jäger, et al.. (2015). Outcomes of resections for pancreatic adenocarcinoma with suspected venous involvement: a single center experience. BMC Surgery. 15(1). 100–100. 9 indexed citations
15.
Nitsche, Ulrich, Patrick Wenzel, Jens T. Siveke, et al.. (2015). Resectability After First-Line FOLFIRINOX in Initially Unresectable Locally Advanced Pancreatic Cancer: A Single-Center Experience. Annals of Surgical Oncology. 22(S3). 1212–1220. 70 indexed citations
16.
Kong, Bo, et al.. (2013). Overview on how oncogenic Kras promotes pancreatic carcinogenesis by inducing low intracellular ROS levels. Frontiers in Physiology. 4. 246–246. 60 indexed citations
17.
Oliveira, Tiago De, Ivane Abiatari, Susanne Raulefs, et al.. (2012). Syndecan-2 promotes perineural invasion and cooperates with K-ras to induce an invasive pancreatic cancer cell phenotype. Molecular Cancer. 11(1). 19–19. 46 indexed citations
18.
Hong, Xin, Christoph Michalski, Bo Kong, et al.. (2010). ALCAM is associated with chemoresistance and tumor cell adhesion in pancreatic cancer. Journal of Surgical Oncology. 101(7). 564–569. 34 indexed citations
19.
Huang, Jing-bin, Yinglong Liu, Cuntao Yu, et al.. (2010). Lung biopsy findings in previously inoperable patients with severe pulmonary hypertension associated with congenital heart disease. International Journal of Cardiology. 151(1). 76–83. 19 indexed citations
20.
Jiang, Xiaohua, Ivane Abiatari, Bo Kong, et al.. (2008). Pancreatic Islet and Stellate Cells Are the Main Sources of Endocrine Gland-Derived Vascular Endothelial Growth Factor/Prokineticin-1 in Pancreatic Cancer. Pancreatology. 9(1-2). 165–172. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026